在患有胃肠道系统癌症的老年患者中,潜在不合适药物的影响
Melike Ozkan1, Irfan Karahan1, Selim Yalcin1
1Kırıkkale University Faculty of Medicine, Department of Internal Medicine, Kirikkale, Turkey.
Medeniyet medical journal
|December 27, 2023
概括
在老年胃肠道癌症患者中,潜在不合适的药物 (PIM) 会增加化疗副作用. PIM没有影响死亡率或进展,但它的存在预测了不良事件.
科学领域:
- 老年瘤学 老年瘤学
- 临床药房 临床药房
- 胃肠病学 胃肠病学
背景情况:
- 潜在不合适的药物 (PIM) 对老年人构成重大风险.
- 癌症患者,尤其是患有胃肠道恶性瘤的患者,面临着更复杂的处方和不遵守处方.
- 了解PIM的影响对于优化老年癌症护理至关重要.
研究的目的:
- 为了评估PIM在患有胃肠道癌症的患者的影响.
- 调查PIM与化疗副作用,死亡率和疾病进展之间的关系.
主要方法:
- 对154名胃肠道癌症患者进行了回顾性队列研究.
- 使用"时间到停止"标准评估PIM.
- 评估PIM与生存和不良治疗事件的关联.
主要成果:
- 在68.1%的患者中检测到PIM.
- 化疗副作用在PIM组 (OR=5.6) 中明显更常见.
- PIM没有影响死亡率或无进展生存率;年龄,阶段和实验室值是关键的死亡率因素.
结论:
- 诊断时的PIM可能会增加化疗毒性.
- PIM是化疗副作用的重要预测因素.
- 尽量减少PIM可能会减少老年癌症患者的不良治疗事件.
相关概念视频
Factors Influencing Drug Absorption: Disease States and Pharmacology
520
Multiple disease states can significantly influence the oral drug absorption process by affecting blood flow and the functionality of the gastrointestinal (GI) system. Various GI diseases, including conditions that alter GI motility, such as diarrhea, decreased acid secretions (achlorhydria), and infections, have been associated with reduced drug absorption.
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
520
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
206
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
206
Factors Affecting Drug Response: Overview
2.0K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.0K
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
262
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
262
Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents
218
Diarrhea is characterized by the occurrence of frequent, watery bowel movements. Various factors can trigger diarrhea, including viral or bacterial infections, foodborne illnesses, side effects from certain medications, and underlying digestive disorders. If not adequately managed, diarrhea can lead to complications such as dehydration, electrolyte imbalances, and nutrient deficiencies. Severe diarrhea can lead to significant weight loss, malnutrition, and weakened immune function.
Adsorbents...
Adsorbents...
218
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
329
Prokinetic agents are specialized medications that stimulate gastrointestinal (GI) motility, promoting food movement through the GI tract. Dopamine, an inhibitory neurotransmitter, plays a significant role in this process, reducing GI motility and indirectly controlling the speed of digestion. Dopamine receptor antagonists, such as metoclopramide and domperidone, offer a unique advantage as prokinetic agents. By blocking the dopamine receptors, these drugs increase GI motility, improving food...
329


